363 related articles for article (PubMed ID: 17206139)
1. Cyclostreptin binds covalently to microtubule pores and lumenal taxoid binding sites.
Buey RM; Calvo E; Barasoain I; Pineda O; Edler MC; Matesanz R; Cerezo G; Vanderwal CD; Day BW; Sorensen EJ; López JA; Andreu JM; Hamel E; Díaz JF
Nat Chem Biol; 2007 Feb; 3(2):117-25. PubMed ID: 17206139
[TBL] [Abstract][Full Text] [Related]
2. Cyclostreptin (FR182877), an antitumor tubulin-polymerizing agent deficient in enhancing tubulin assembly despite its high affinity for the taxoid site.
Edler MC; Buey RM; Gussio R; Marcus AI; Vanderwal CD; Sorensen EJ; Díaz JF; Giannakakou P; Hamel E
Biochemistry; 2005 Aug; 44(34):11525-38. PubMed ID: 16114889
[TBL] [Abstract][Full Text] [Related]
3. Cyclostreptin and microtubules: is a low-affinity binding site required?
Prussia AJ; Yang Y; Geballe MT; Snyder JP
Chembiochem; 2010 Jan; 11(1):101-9. PubMed ID: 19946930
[TBL] [Abstract][Full Text] [Related]
4. Interaction of a cyclostreptin analogue with the microtubule taxoid site: the covalent reaction rapidly follows binding.
Bai R; Vanderwal CD; Díaz JF; Hamel E
J Nat Prod; 2008 Mar; 71(3):370-4. PubMed ID: 18298077
[TBL] [Abstract][Full Text] [Related]
5. Cyclostreptin derivatives specifically target cellular tubulin and further map the paclitaxel site.
Calvo E; Barasoain I; Matesanz R; Pera B; Camafeita E; Pineda O; Hamel E; Vanderwal CD; Andreu JM; López JA; Díaz JF
Biochemistry; 2012 Jan; 51(1):329-41. PubMed ID: 22148836
[TBL] [Abstract][Full Text] [Related]
6. The microtubule-pore gatekeeper.
Snyder JP
Nat Chem Biol; 2007 Feb; 3(2):81-2. PubMed ID: 17235340
[No Abstract] [Full Text] [Related]
7. Distinct pose of discodermolide in taxol binding pocket drives a complementary mode of microtubule stabilization.
Khrapunovich-Baine M; Menon V; Verdier-Pinard P; Smith AB; Angeletti RH; Fiser A; Horwitz SB; Xiao H
Biochemistry; 2009 Dec; 48(49):11664-77. PubMed ID: 19863156
[TBL] [Abstract][Full Text] [Related]
8. Insights into the interaction of discodermolide and docetaxel with tubulin. Mapping the binding sites of microtubule-stabilizing agents by using an integrated NMR and computational approach.
Canales A; Rodríguez-Salarichs J; Trigili C; Nieto L; Coderch C; Andreu JM; Paterson I; Jiménez-Barbero J; Díaz JF
ACS Chem Biol; 2011 Aug; 6(8):789-99. PubMed ID: 21539341
[TBL] [Abstract][Full Text] [Related]
9. Tubulin assembly, taxoid site binding, and cellular effects of the microtubule-stabilizing agent dictyostatin.
Madiraju C; Edler MC; Hamel E; Raccor BS; Balachandran R; Zhu G; Giuliano KA; Vogt A; Shin Y; Fournier JH; Fukui Y; Brückner AM; Curran DP; Day BW
Biochemistry; 2005 Nov; 44(45):15053-63. PubMed ID: 16274252
[TBL] [Abstract][Full Text] [Related]
10. Structural Basis of Microtubule Stabilization by Discodermolide.
Prota AE; Bargsten K; Redondo-Horcajo M; Smith AB; Yang CH; McDaid HM; Paterson I; Horwitz SB; Fernando Díaz J; Steinmetz MO
Chembiochem; 2017 May; 18(10):905-909. PubMed ID: 28207984
[TBL] [Abstract][Full Text] [Related]
11. Cell-based and biochemical structure-activity analyses of analogs of the microtubule stabilizer dictyostatin.
Raccor BS; Vogt A; Sikorski RP; Madiraju C; Balachandran R; Montgomery K; Shin Y; Fukui Y; Jung WH; Curran DP; Day BW
Mol Pharmacol; 2008 Mar; 73(3):718-26. PubMed ID: 18073274
[TBL] [Abstract][Full Text] [Related]
12. The microtubule-stabilizing agent discodermolide competitively inhibits the binding of paclitaxel (Taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel, and inhibits the growth of paclitaxel-resistant cells.
Kowalski RJ; Giannakakou P; Gunasekera SP; Longley RE; Day BW; Hamel E
Mol Pharmacol; 1997 Oct; 52(4):613-22. PubMed ID: 9380024
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of natural product microtubule stabilizers on microtubule assembly: single agent and combination studies with taxol, epothilone B, and discodermolide.
Gertsch J; Meier S; Müller M; Altmann KH
Chembiochem; 2009 Jan; 10(1):166-75. PubMed ID: 19058273
[TBL] [Abstract][Full Text] [Related]
14. Microtubule interactions with chemically diverse stabilizing agents: thermodynamics of binding to the paclitaxel site predicts cytotoxicity.
Buey RM; Barasoain I; Jackson E; Meyer A; Giannakakou P; Paterson I; Mooberry S; Andreu JM; Díaz JF
Chem Biol; 2005 Dec; 12(12):1269-79. PubMed ID: 16356844
[TBL] [Abstract][Full Text] [Related]
15. Possible binding site for paclitaxel at microtubule pores.
Magnani M; Maccari G; Andreu JM; Díaz JF; Botta M
FEBS J; 2009 May; 276(10):2701-12. PubMed ID: 19459933
[TBL] [Abstract][Full Text] [Related]
16. Methods for studying microtubule binding site interactions: zampanolide as a covalent binding agent.
Field JJ; Calvo E; Northcote PT; Miller JH; Altmann KH; Díaz JF
Methods Cell Biol; 2013; 115():303-25. PubMed ID: 23973080
[TBL] [Abstract][Full Text] [Related]
17. Peloruside A does not bind to the taxoid site on beta-tubulin and retains its activity in multidrug-resistant cell lines.
Gaitanos TN; Buey RM; Díaz JF; Northcote PT; Teesdale-Spittle P; Andreu JM; Miller JH
Cancer Res; 2004 Aug; 64(15):5063-7. PubMed ID: 15289305
[TBL] [Abstract][Full Text] [Related]
18. Synergistic suppression of microtubule dynamics by discodermolide and paclitaxel in non-small cell lung carcinoma cells.
Honore S; Kamath K; Braguer D; Horwitz SB; Wilson L; Briand C; Jordan MA
Cancer Res; 2004 Jul; 64(14):4957-64. PubMed ID: 15256469
[TBL] [Abstract][Full Text] [Related]
19. Wild-type class I beta-tubulin sensitizes Taxol-resistant breast adenocarcinoma cells harboring a beta-tubulin mutation.
Wiesen KM; Xia S; Yang CP; Horwitz SB
Cancer Lett; 2007 Nov; 257(2):227-35. PubMed ID: 17869412
[TBL] [Abstract][Full Text] [Related]
20. Taccalonolide binding to tubulin imparts microtubule stability and potent in vivo activity.
Risinger AL; Li J; Bennett MJ; Rohena CC; Peng J; Schriemer DC; Mooberry SL
Cancer Res; 2013 Nov; 73(22):6780-92. PubMed ID: 24048820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
